These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30576525)

  • 1. Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
    Dinges DF; Basner M; Ecker AJ; Baskin P; Johnston SL
    Sleep; 2019 Mar; 42(3):. PubMed ID: 30576525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
    Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
    J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
    J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m.
    Beaumont M; Batéjat D; Coste O; Van Beers P; Colas A; Clère JM; Piérard C
    Neuropsychobiology; 2004; 49(3):154-62. PubMed ID: 15034230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.
    Danjou P; Paty I; Fruncillo R; Worthington P; Unruh M; Cevallos W; Martin P
    Br J Clin Pharmacol; 1999 Sep; 48(3):367-74. PubMed ID: 10510148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
    Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
    Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude.
    Beaumont M; Batéjat D; Piérard C; Van Beers P; Philippe M; Léger D; Savourey G; Jouanin JC
    Sleep; 2007 Nov; 30(11):1527-33. PubMed ID: 18041485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
    Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
    Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance following a sudden awakening from daytime nap induced by zaleplon.
    Whitmore JN; Fischer JR; Barton EC; Storm WF
    Aviat Space Environ Med; 2004 Jan; 75(1):29-36. PubMed ID: 14736130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
    Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
    Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performance following premature awakening from zolpidem or melatonin induced daytime sleep.
    Storm WF; Eddy DR; Welch CB; Hickey PA; Fischer J; Cardenas R
    Aviat Space Environ Med; 2007 Jan; 78(1):10-20. PubMed ID: 17225476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of zolpidem on cognitive function and postural control at high altitude.
    Bouzat P; Séchaud G; Banco P; Davranche K; Casini L; Baillieul S; Manhes P; Botrè F; Mazzarino M; De la Torre X; Robach P; Verges S
    Sleep; 2018 Oct; 41(10):. PubMed ID: 30099547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypnotic efficacy of zaleplon for daytime sleep in rested individuals.
    Whitmore JN; Fischer JR; Storm WF
    Sleep; 2004 Aug; 27(5):895-8. PubMed ID: 15453547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation.
    Hall-Porter JM; Schweitzer PK; Eisenstein RD; Ahmed HA; Walsh JK
    J Clin Sleep Med; 2014 Jan; 10(1):27-34. PubMed ID: 24426817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
    Paul MA; Gray G; Kenny G; Pigeau RA
    Aviat Space Environ Med; 2003 Dec; 74(12):1263-70. PubMed ID: 14692469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of temazepam and zaleplon to induce afternoon sleep.
    Simons R; Koerhuis CL; Valk PJ; Van den Oord MH
    Mil Med; 2006 Oct; 171(10):998-1001. PubMed ID: 17076453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
    Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of zolpidem/triazolam on cognitive performance 12 hours after acute administration.
    Matsunaga Y; Tagaya H; Fukase Y; Hakamata Y; Murayama N; Kumagai Y; Kuroyama M
    Sleep Med; 2018 Dec; 52():213-218. PubMed ID: 30097333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.